Welcome to Pritzker | Ruohonen

Rocephin Linked to Death of Newborns

The following information on Rcephin is provided by the law firm of Pritzker | Ruohonen.  Attorney Fred Pritzker has a national reputation in the area of product liability litigation and has been interviewed by the New York Times, Wall Street Journal and other publications.  In recognition of his accomplishments, other lawyers have selected him for inclusion in The Best Lawyers in America.  To contact Pritzker | Ruohonen please call toll-free at 1-888-377-8900 or submit the firm's online consultation form.

ROCEPHIN WARNING
Rocephin (ceftriaxone sodium) has been linked to the deaths of newborn infants.  The babies most at risk are premature infants who are hyperbilirubinemic (a condition associated with jaundice).  As a result, Roche, the manufacturer of Rocephin, issued a letter to healthcare professionals warning of the potential risk and advising them of Roche’s update to the Rocephin for injection prescribing information.

The new prescribing information specifically states that hyperbilirubinemic neonates (newborns) should not be treated with Rocephin.  In addition, the new information states that calcium-containing solutions should not be administered in conjunction with Rocephin because the infant deaths involved calcium-ceftriaxone precipates in the lungs and kidneys.  Calcium-containing solutions should not be used with Rocephin in any way, including the following:

  1. For reconstitution of the Rocephin prior to administration of Rocephin by injection
  2. With the Rocephin using different infusion lines
  3. At around the same time as Rocephin

Research indicates that ceftriaxone (found in Rocephin) can displace bilirubin from its binding to serum albumin and bilirubin encephalopathy can possibly develop in these patients. Bilirubin encephalopathy can cause brain damage or death

If your child has died or suffered injury to the lungs, kidneys, or brain after administration of Rocephin, please contact the law firm of Pritzker | Ruohonen for a free consultation by calling toll-free at 1-888-377-8900 or submitting the firm’s online consultation form.  A case based on the administration of Rocephin may involve both product liability and medical malpractice issues.  If your baby has kidney problems, lung damage, or brain damage, it may be due to the administration of Rocephin or another medication.  It could also be due to other malpractice-related birth injuries. 


Free Case Consultation





Logos

Firm News

Fred Pritzker Listed in The Best Lawyers in America

Fred Pritzker has been notified that he will again be listed in The Best Lawyers in America for his work in personal injury litigation.

 

Pain and Suffering

Rich Ruohonen recently chaired a legal seminar on obtaining compensation for pain and suffering in a personal injury case. Rich uses his knowledge, experience, and reputation to maximize recoveries for clients.

 

Medtronic Recall and Medtronic Lawsuit

FDA has annonced a Medtronic Spring Fidelis defibrillator lead recall. Two of our clients with defective Medtronic leads were shocked over twenty times before medical professionals were able to turn off the defibrillator.

 

Fleet Lawsuit

We are representing several people who experienced kidney failure (acute phosphate nephropathy) after use of Fleet Phospho-soda solution or Fleet Accu-Prep solution for bowel cleansing.

 

Ortho Evra Lawsuit: Ortho Evra Birth Control Patch

The Ortho Evra birth control patch has been linked to an increased risk of blood clots that can lead to pulmonary embolism, stroke and heart attack.

 

Trasylol Recall

Bayer has agreed to a marketing suspension of Trasylol, a drug used to control bleeding during heart surgery, pending detailed review of preliminary results from a Canadian study that suggested an increased risk for death.

 

Fentanyl Lawsuit and Fentanyl Recall

There have been a number of recalls regarding fentanyl due to the risk of a fentanyl overdose.

 

Fosamax and Osteonecrosis

Several cases of bisphosphonate-associated osteonecrosis of the jaw have been associated with the use of oral bisphosphonates, including Fosamax®, Actonel®, and other medications.